Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A3 | Q9HAS3 | 4/20 | 0.56 |
| ▸ | SLC5A1 | P13866 | 2/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.46 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | TYR | P14679 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | P4HB | P07237 | 1/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4636160 | 0.91 | SLC28A3 (0.58) | SLC28A3SLC5A1HIF1AEPHX2SLC5A2 | |
| SCHEMBL4636191 | 0.87 | SLC28A3 (0.61) | SLC28A3SLC5A1HIF1AEPHX2SLC5A2 | |
| SCHEMBL940123 | 0.86 | SLC28A3 (0.57) | SLC28A3SLC5A1HIF1ASLC5A2TYR | |
| SCHEMBL942070 | 0.85 | SLC28A3 (0.71) | SLC28A3SLC5A1HIF1AEPHX2SLC5A2 | |
| SCHEMBL4635629 | 0.84 | SLC28A3 (0.57) | SLC28A3SLC5A1HIF1AEPHX2SLC5A2 | |
| SCHEMBL4635305 | 0.83 | SLC28A3 (0.61) | SLC28A3SLC5A1HIF1AEPHX2SLC5A2 | |
| SCHEMBL941363 | 0.81 | NPC1 (0.55) | SLC28A3TYRCA12CA2AKR1B1 | |
| SCHEMBL941333 | 0.81 | NPC1 (0.63) | SLC28A3SLC5A1TYRAKR1B1 | |
| SCHEMBL30803032 | 0.80 | SLC28A3 (0.53) | SLC28A3SLC5A1HIF1AEPHX2SLC5A2 | |
| SCHEMBL4636214 | 0.80 | SLC28A3 (0.56) | SLC28A3SLC5A1EPHX2SLC5A2TYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1932514-B1 | PHARMACEUTICAL PREPARATION FOR EXTERNAL APPLICATION TO SKIN COMPRISING PHOSPHORYLATED SUGAR | EZAKI GLICO CO (JP) | 2018-11-14 | — | — | EP | disclosed |
| US-20140023602-A1 | EXTERNAL PREPARATION FOR SKIN CONTAINING A PHOSPHORYLATED SACCHARIDE | EZAKI GLICO CO., LTD. (JP) | 2014-01-23 | — | — | US | disclosed |
| US-20080274068-A1 | External Preparation for Skin Containing a Phosphorlated Saccharide | EZAKI GLICO CO., LTD. (JP) | 2008-11-06 | — | — | US | disclosed |
| EP-1932514-A1 | PHARMACEUTICAL PREPARATION FOR EXTERNAL APPLICATION TO SKIN COMPRISING PHOSPHORYLATED SUGAR | Ezaki Glico Co., Ltd. (JP) | 2008-06-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140023602-A1 | EXTERNAL PREPARATION FOR SKIN CONTAINING A PHOSPHORYLATED SACCHARIDE | SI, CUTA, CD44 | SLC28A3 1164/4885SLC5A1 723/4885HIF1A 634/4885 |
| US-20080274068-A1 | External Preparation for Skin Containing a Phosphorlated Saccharide | CUTA, SI, CD44 | SLC28A3 977/4885SLC5A1 589/4885HIF1A 658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.